Colony Bankcorp Financials
This page shows Colony Bankcorp (CBAN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Colony Bankcorp's revenue grew 9.9% year-over-year to $137.2M, a solid pace of expansion. This earns a growth score of 57/100.
Colony Bankcorp carries a low D/E ratio of 0.89, meaning only $0.89 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 78/100, indicating a strong balance sheet with room for future borrowing.
Colony Bankcorp converts 16.3% of revenue into free cash flow ($22.3M). This strong cash generation earns a score of 81/100.
Colony Bankcorp's ROE of 8.6% shows moderate profitability relative to equity, earning a score of 34/100. This is up from 8.5% the prior year.
Colony Bankcorp passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Colony Bankcorp generates $0.98 in operating cash flow ($23.4M OCF vs $23.9M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Colony Bankcorp generated $137.2M in revenue in fiscal year 2024. This represents an increase of 9.9% from the prior year.
Colony Bankcorp generated $22.3M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 28.5% from the prior year.
Colony Bankcorp reported $23.9M in net income in fiscal year 2024. This represents an increase of 9.8% from the prior year.
Colony Bankcorp earned $1.36 per diluted share (EPS) in fiscal year 2024. This represents an increase of 9.7% from the prior year.
Colony Bankcorp held $231.0M in cash against $248.0M in long-term debt as of fiscal year 2024.
Colony Bankcorp paid $0.45 per share in dividends in fiscal year 2024. This represents an increase of 2.3% from the prior year.
Colony Bankcorp had 18M shares outstanding in fiscal year 2024. This represents a decrease of 0.3% from the prior year.
Colony Bankcorp's net profit margin was 17.4% in fiscal year 2024, showing the share of revenue converted to profit. This is down 0.0 percentage points from the prior year.
Colony Bankcorp's ROE was 8.6% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 0.0 percentage points from the prior year.
Colony Bankcorp spent $1.3M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 221.4% from the prior year.
Colony Bankcorp invested $1.1M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 70.1% from the prior year.
CBAN Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $36.9M+0.2% | $36.8M+3.7% | $35.5M-1.3% | $36.0M+4.0% | $34.6M+3.8% | $33.3M+0.1% | $33.3M+0.3% | $33.2M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $14.2M-1.8% | $14.4M-0.8% | $14.6M-6.1% | $15.5M-3.4% | $16.1M+7.6% | $14.9M+1.8% | $14.7M+2.3% | $14.3M |
| Income Tax | $1.5M-28.9% | $2.1M+23.4% | $1.7M+16.5% | $1.4M+1.3% | $1.4M-3.0% | $1.5M+2.9% | $1.4M-5.6% | $1.5M |
| Net Income | $5.8M-27.1% | $8.0M+20.6% | $6.6M-11.0% | $7.4M+32.0% | $5.6M+2.8% | $5.5M+2.6% | $5.3M-4.7% | $5.6M |
| EPS (Diluted) | $0.33-28.3% | $0.46+21.1% | $0.38-11.6% | $0.43+34.4% | $0.32+3.2% | $0.31+3.3% | $0.30-6.3% | $0.32 |
CBAN Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.2B+1.2% | $3.1B-1.8% | $3.2B+2.0% | $3.1B+1.5% | $3.1B+1.9% | $3.0B-0.3% | $3.0B-1.2% | $3.1B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $200.0M+78.3% | $112.1M-49.3% | $221.2M-4.3% | $231.0M+59.5% | $144.9M+76.6% | $82.0M-13.4% | $94.7M+13.6% | $83.3M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $50.9M0.0% | $50.9M+4.0% | $48.9M0.0% | $48.9M0.0% | $48.9M0.0% | $48.9M0.0% | $48.9M0.0% | $48.9M |
| Total Liabilities | $2.9B+1.0% | $2.8B-2.2% | $2.9B+1.9% | $2.8B+1.5% | $2.8B+1.7% | $2.7B-0.5% | $2.8B-1.5% | $2.8B |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | $248.0M | N/A | N/A | N/A | $238.4M |
| Total Equity | $302.3M+2.9% | $293.9M+2.4% | $286.9M+3.0% | $278.7M+1.0% | $276.1M+4.3% | $264.7M+1.9% | $259.9M+2.0% | $254.9M |
| Retained Earnings | $154.7M+2.5% | $150.9M+4.1% | $145.0M+3.3% | $140.4M+4.0% | $134.9M+2.8% | $131.3M+2.7% | $127.8M+2.7% | $124.4M |
CBAN Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $14.4M-9.0% | $15.8M-11.7% | $17.9M+653.3% | -$3.2M-115.8% | $20.5M+1729.9% | $1.1M-77.7% | $5.0M-12.9% | $5.8M |
| Capital Expenditures | $351K+312.9% | $85K-75.4% | $346K-38.4% | $562K+95.8% | $287K+120.8% | $130K+28.7% | $101K-84.1% | $634K |
| Free Cash Flow | $14.1M-10.8% | $15.8M-10.5% | $17.6M+562.5% | -$3.8M-118.8% | $20.2M+1941.2% | $990K-79.9% | $4.9M-4.1% | $5.1M |
| Investing Cash Flow | $47.5M+185.5% | -$55.6M+30.1% | -$79.6M-262.7% | $49.0M+14217.0% | $342K-64.0% | $951K-98.1% | $50.9M+1057.0% | -$5.3M |
| Financing Cash Flow | $25.9M+137.3% | -$69.3M-233.5% | $51.9M+28.2% | $40.5M-3.7% | $42.0M+385.1% | -$14.7M+66.9% | -$44.6M+23.8% | -$58.5M |
| Dividends Paid | $2.0M+0.1% | $2.0M-0.4% | $2.0M+2.1% | $2.0M-0.1% | $2.0M-0.1% | $2.0M+0.1% | $2.0M+2.3% | $1.9M |
| Share Buybacks | $0-100.0% | $959K+52.2% | $630K+16.7% | $540K+2.7% | $526K+120.1% | $239K | $0 | $0 |
CBAN Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 15.8%-5.9pp | 21.7%+3.0pp | 18.6%-2.0pp | 20.6%+4.4pp | 16.3%-0.2pp | 16.4%+0.4pp | 16.0%-0.9pp | 16.9% |
| Return on Equity | 1.9%-0.8pp | 2.7%+0.4pp | 2.3%-0.4pp | 2.7%+0.6pp | 2.0%-0.0pp | 2.1%+0.0pp | 2.1%-0.1pp | 2.2% |
| Return on Assets | 0.2%-0.1pp | 0.3%+0.1pp | 0.2%-0.0pp | 0.2%+0.1pp | 0.2%0.0pp | 0.2%0.0pp | 0.2%0.0pp | 0.2% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 9.43-0.2 | 9.60-0.5 | 10.05+9.2 | 0.89-9.2 | 10.10-0.3 | 10.36-0.2 | 10.60+9.7 | 0.94 |
| FCF Margin | 38.1%-4.7pp | 42.8%-6.8pp | 49.5%+60.1pp | -10.6%-69.0pp | 58.4%+55.4pp | 3.0%-11.8pp | 14.8%-0.7pp | 15.5% |
Similar Companies
Frequently Asked Questions
What is Colony Bankcorp's annual revenue?
Colony Bankcorp (CBAN) reported $137.2M in total revenue for fiscal year 2024. This represents a 9.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Colony Bankcorp's revenue growing?
Colony Bankcorp (CBAN) revenue grew by 9.9% year-over-year, from $124.9M to $137.2M in fiscal year 2024.
Is Colony Bankcorp profitable?
Yes, Colony Bankcorp (CBAN) reported a net income of $23.9M in fiscal year 2024, with a net profit margin of 17.4%.
What is Colony Bankcorp's earnings per share (EPS)?
Colony Bankcorp (CBAN) reported diluted earnings per share of $1.36 for fiscal year 2024. This represents a 9.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
How much debt does Colony Bankcorp have?
As of fiscal year 2024, Colony Bankcorp (CBAN) had $231.0M in cash and equivalents against $248.0M in long-term debt.
What is Colony Bankcorp's net profit margin?
Colony Bankcorp (CBAN) had a net profit margin of 17.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does Colony Bankcorp pay dividends?
Yes, Colony Bankcorp (CBAN) paid $0.45 per share in dividends during fiscal year 2024.
What is Colony Bankcorp's return on equity (ROE)?
Colony Bankcorp (CBAN) has a return on equity of 8.6% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Colony Bankcorp's free cash flow?
Colony Bankcorp (CBAN) generated $22.3M in free cash flow during fiscal year 2024. This represents a 28.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Colony Bankcorp's operating cash flow?
Colony Bankcorp (CBAN) generated $23.4M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Colony Bankcorp's total assets?
Colony Bankcorp (CBAN) had $3.1B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Colony Bankcorp's capital expenditures?
Colony Bankcorp (CBAN) invested $1.1M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
Does Colony Bankcorp buy back shares?
Yes, Colony Bankcorp (CBAN) spent $1.3M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
How many shares does Colony Bankcorp have outstanding?
Colony Bankcorp (CBAN) had 18M shares outstanding as of fiscal year 2024.
What is Colony Bankcorp's debt-to-equity ratio?
Colony Bankcorp (CBAN) had a debt-to-equity ratio of 0.89 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Colony Bankcorp's return on assets (ROA)?
Colony Bankcorp (CBAN) had a return on assets of 0.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Colony Bankcorp's Piotroski F-Score?
Colony Bankcorp (CBAN) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Colony Bankcorp's earnings high quality?
Colony Bankcorp (CBAN) has an earnings quality ratio of 0.98x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Colony Bankcorp?
Colony Bankcorp (CBAN) scores 63 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.